Department of Plastic Surgery, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, "Papageorgiou" Hospital, Thessaloniki, Greece.
3rd Department of Nuclear Medicine, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, "Papageorgiou" Hospital, Thessaloniki, Greece.
J Surg Oncol. 2019 Nov;120(6):911-918. doi: 10.1002/jso.25650. Epub 2019 Aug 2.
A new technique named "Selected Lymph Node" ("SeLyN") was evaluated, aiming to identify the most functional groin lymph nodes (LNs) for an effective LN transplantation.
Bilateral lower-limb SPECT-CT was performed in the upper-limb lymphedema patients, to select the most radioactive inguinal LN. Recorded data included demographics, stage, etiology of lymphedema, flap consistency in accordance to preoperative findings, flap size, number of LN, and harvesting time. Infection episodes per year and volume changes of the upper limbs were documented. Donor-site complications were recorded and lower-limb evaluation was performed through clinical examination, volume analysis, and lymphoscintigraphy.
A total of 41 patients underwent a "SeLyN" transfer technique. The mean flap size was 28.34 cm containing a mean of 3.4 LNs. The mean time spent on flap harvest was 39 minutes. A mean 56.5% volume reduction (P < .001) and a mean 1.41 to 0.29 infection episodes per patient per year (P < .001) were recorded. Clinical evaluation and lymphography of the donor site advocated no major complications for a mean follow-up period of 42.5 months.
"SeLyN" is a safe and effective technique in selecting the most suitable LNs, minimizing the donor-site morbidity, and decreasing the overall operating time.
一种名为“选择淋巴结”(“SeLyN”)的新技术被评估,旨在确定最具功能的腹股沟淋巴结(LNs)以进行有效的淋巴结移植。
对上肢淋巴水肿患者进行双侧下肢 SPECT-CT,以选择放射性最强的腹股沟 LN。记录的数据包括人口统计学特征、分期、淋巴水肿的病因、根据术前发现的皮瓣一致性、皮瓣大小、LN 数量和采集时间。每年上肢体积变化和感染次数。记录供体部位并发症,并通过临床检查、体积分析和淋巴闪烁显像对下肢进行评估。
共有 41 例患者接受了“SeLyN”转移技术。平均皮瓣大小为 28.34cm,包含平均 3.4 个 LN。皮瓣采集时间平均为 39 分钟。上肢体积平均减少 56.5%(P<.001),平均每年每位患者的感染次数从 1.41 次减少到 0.29 次(P<.001)。供体部位的临床评估和淋巴造影术表明,在平均 42.5 个月的随访期间,没有出现重大并发症。
“SeLyN”是一种安全有效的选择最适合的淋巴结的技术,可最大程度地降低供体部位的发病率并减少总手术时间。